Asia Pacific Interventional Cardiology Devices Market Size & Outlook

The interventional cardiology devices market in Asia Pacific is expected to reach a projected revenue of US$ 3,934.7 million by 2030. A compound annual growth rate of 8.1% is expected of Asia Pacific interventional cardiology devices market from 2024 to 2030.

Revenue, 2023 (US$M)
$2,282.6
Forecast, 2030 (US$M)
$3,934.7
CAGR, 2024 - 2030
8.1%
Report Coverage
Asia Pacific

Asia Pacific interventional cardiology devices market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific interventional cardiology devices market highlights

  • The Asia Pacific interventional cardiology devices market generated a revenue of USD 2,282.6 million in 2023.
  • The market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
  • In terms of segment, coronary stents was the largest revenue generating product in 2023.
  • Accessory Devices is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 2,282.6 million
Market revenue in 2030USD 3,934.7 million
Growth rate8.1% (CAGR from 2023 to 2030)
Largest segmentCoronary stents
Fastest growing segmentAccessory Devices
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIntravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.0% of the global interventional cardiology devices market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,934.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Cardiology Devices Market Scope

Interventional cardiology devices market segmentation & scope
Intravascular Imaging Catheters and Pressure Guidewires
DES
BMS
BRS
Normal
Specialty
DCB
PTCA Guidewires
PTCA Guiding Catheters
Introducer Sheaths

Interventional Cardiology Devices Market Companies

Name Profile # Employees HQ Website

Asia Pacific interventional cardiology devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.


Coronary stents was the largest segment with a revenue share of 50.87% in 2023. Horizon Databook has segmented the Asia Pacific interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific is estimated to witness the fastest growth rate during the forecast period. The high geriatric population, growing risk of heart diseases, and unmet clinical needs are primary factors driving the region’s growth. Furthermore, improving healthcare infrastructure, increasing patient awareness, and rising healthcare expenditure levels in the region are expected to assist manufacturers in capitalizing on these available opportunities.


In January 2021, the Chinese government introduced a centralized procurement process for high-value medical consumables, resulting in a substantial decrease in the expenses associated with Drug-eluting Stents (DES). This move led to increased affordability and accessibility of interventional cardiology procedures using these stents, thereby driving market demand and growth in China.


Moreover, technological advancements in the region are another factor contributing to market growth. Companies in the Asia Pacific region, particularly in countries such as Japan, South Korea, China, and India, have been developing innovative interventional cardiology devices. These include advanced stents, catheters, balloons, and imaging technologies used in procedures such as angioplasty & stent placement.

Reasons to subscribe to Asia Pacific interventional cardiology devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific interventional cardiology devices market databook

  • Our clientele includes a mix of interventional cardiology devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific interventional cardiology devices market size, by country, 2018-2030 (US$M)

Asia Pacific Interventional Cardiology Devices Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific interventional cardiology devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more